Centre reserves 30 crore doses of Biological E's Covid-19 vaccine with an advance payment of ₹1,500 crore
The vaccine candidate is undergoing phase 3 trials now
Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine candidate is undergoing phase 3 trials now
The vaccines will be manufactured and stockpiled by Biological-E from August-December 2021
According to sources, the government has signed the deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees (USD 205.62 million).
>> Reuters Published: 03 Jun 2021 10:26 AM BdST Updated: 03 Jun 2021 10:26 AM BdST FILE PHOTO: 3D-printed small toy figurines, a syringe and vial labelled "coronavirus disease (COVID-19) vaccine" are seen in front of India flag in this illustration taken May 4, 2021. REUTERS/Dado Ruvic/Illustration/File Photo India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million). "); } The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available ...
The Ministry added that it would be making an advance payment of Rs. 1500 crore to the firm.